Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mayne Pharma Names U.S. Ops VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Mayne Pharma Names U.S. Ops VP

Lewis responsible for managing all quality-related functions

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Q. Dwight Lewis has been appointed vice president of quality for Mayne Pharma’s operations in the U.S. Mr. Lewis is responsible for managing all quality-related functions to ensure U.S. pharmaceutical operations, from labs to manufacturing lines, continue to comply with global regulatory and industry standards.
 
Prior to joining the company, Mr. Lewis was senior director of quality for Teva Pharmaceuticals, where he managed quality assurance and control functions for solid dose manufacturing. He also served as vice president of quality for Irix Pharmaceuticals, and director of quality operations for DSM Pharmaceuticals.
 
“Drug product integrity doesn’t occur spontaneously; it is the result of thoughtfully considered and deliberately executed quality standards and operations,” said Stefan Cross, president of Mayne Pharma’s U.S. operations. “Dwight’s knowledge and expertise in quality compliance and assurance will support Mayne Pharma’s ability to deliver superior pharmaceutical services and products to our clients and the patients we collectively serve.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters